MOTS-c care / a field guide
Looking for a
MOTS-c provider?
This is a guide to finding care. Let’s start with the question behind the search: has MOTS-c been cleared as a medicine?
As of September 2026, the US Food and Drug Administration (FDA) has not approved any MOTS-c medicine.
Read the short answerSeparate the questions
An offer
An approval
The misconception
“Removed from the FDA’s safety warning list” means a pharmacy can make it.
- What it can sound like
- The FDA keeps a list of ingredients with safety concerns. If an ingredient leaves that list, it can sound as though the concern has gone away.
- The short answer
The people who asked the FDA to allow pharmacies to make MOTS-c took back their request.
As of September 2026, taking back that request grants no permission for a pharmacy to make MOTS-c.
Making a medicine to order by a pharmacist or doctor is called compounding.
MOTS-c now appears in a separate FDA table for ingredients whose requests were taken back.
The FDA still prints its safety concerns beside MOTS-c in that table.
The next questions
What sits behind the name
What is MOTS-c?
MOTS-c is a peptide: a small chain of the parts that make proteins.
Its recipe sits in mitochondria, the tiny parts of cells that make energy.
Your body makes MOTS-c of its own.
What is still unknown?
As of September 2026, no published study reports giving MOTS-c itself to people as a treatment.
The FDA’s review found no human safety studies, so the risks in people remain unknown.
You can ask about MOTS-c without deciding to use it.
Can a pharmacy make it?
As of September 2026, MOTS-c fails all the ingredient checks required by US law for a regular pharmacy to make it to order.
It has no entry in the official drug reference books that say how to check an ingredient’s identity and quality.
No FDA-approved drug uses MOTS-c as an ingredient.
It is not on the FDA’s list of ingredients allowed for this use.
Under these US rules, a regular pharmacy cannot legally make MOTS-c medicine to order.
FDA staff recommended leaving MOTS-c off that allowed list.
A group that advises the FDA discussed MOTS-c.
As of September 2026, no record of that group’s vote had been published by the FDA.
Even a yes vote from that group would only be advice.
Before the allowed list can change, the FDA must propose a rule, invite public comment and then make its final decision.
Follow your question
Where to go next
Before a conversation
How do I check care?
Start with the person, their licence and the questions you want answered.
Before comparing a quote
What would I be paying for?
Put the visit, any tests and any medicine charge on separate lines.
Look closer
What do the studies actually show?
Separate mouse results, measurements in people and a treatment study still awaiting results.